From January 1 to February 10, 2023, two probable and six suspected cases of LF were recorded. The two probable cases, aged 10 months old and 24 years old, died on January 25 and 26 respectively unreported. All six suspected cases were investigated, of them, two cases tested positive for Lassa fever antigen.  On 28 January 2023, a 21-year-old female (case-patient 1), presented with fever, cough, and chest pain. On January 29, 2023, she was treated for malaria and later started bleeding. On January 31, 2023, she returned to her village and died on the same day. On January 29, 2023, a 57-year-old female, mother of case-patient 1, developed fever, cough, and headache. On February 2, 2023, she presented to a hospital with bleeding and died on arrival. All cases (confirmed and probable) lived in the same house. The case fatality rate (CFR) was 100%. No additional cases were identified and none of the contacts developed LF symptoms. Rodent droppings were found in case-patients' residences. 
